Whatech

Whatech
Share

Whatech

 •  November 7

Currently amounting to $xx million, the global pharmacovigilance and Drug Safety software market is expected to reach a value of $XX Million by 2020 with a CAGR of XX%.Report: www.orbisresearch.com/contacts/request-sample/220318 .Pharmacovigilance software is a drug safety management software solution that supports case management, report...

Whatech

 •  November 2

Analysis of Drug Discovery Services Industry Key Manufacturers Albany Molecular Research Inc. (AMRI) (US), Charles River Laboratories International (US), Evotec (Germany), GenScript (US), Covance (US), WuXi AppTec (China), Pharmaceutical Product Development LLC (PPD) (US), Jubilant Biosys (India), GE Healthcare (US), Merck (Germany), Piramal...

Whatech

 •  October 11

The Global collaborative pharmaceutical robots market is expected to register a robust CAGR over the forecast period. Moreover, collaborative pharmaceutical robots market is anticipated to reach USD 410.1 million globally by 2024.
The market is expected to expand on the back of growing adoption of innovative technology to curb the operational cost...

Whatech

 •  September 18

The prevalence of diseases such as diabetes, osteoarthritis, cardiovascular diseases, Alzheimer's & many others, are higher among the elderly. As per the Arthritis Foundation, the older population in the U.S. affected by arthritis would grow to 21% by 2040 from the current value of 15%. The prevalence of osteoarthritis increases with age and is...

Whatech

 •  September 12

This report studies Pharmacovigilance and Drug Safety Software in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2017, and forecast to 2022. This market is explained on demographics establishments also.
The...

Whatech

 •  September 8

This report studies Pharmacovigilance and Drug Safety Software in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2017, and forecast to 2022. The geographical segmentation of the Global Pharmacovigilance and Drug...

Whatech

 •  September 6

The market evaluation of the region is anticipated to be around 45.4% of the entire market, by the end of 2023. Even though the statistics are likely to drop as compared to those in 2014, but still the region is expected to dominate without any competition or external obstruction. View Full Report:...

Whatech

 •  August 31

The demand for fragment-based drug discovery, however, is expected to be greatly hindered by the lowered potency of fragment screening, the most popular component, in certain compounds. The drugs generated have a lower than required potency, thus deterring several end users from approaching this technique. The collective impact of all such drivers...

Whatech

 •  August 24

- Advertising - In the mid decades, there were only a handful of specialty drugs on the market. These handfuls of pharmacy drugs only focused on treating a limited number of cancers and rare diseases. Today there are hundreds of specialty drugs available, giving patient’s unprecedented accesses to potentially life-changing treatments. Scope &...

Whatech

 •  August 19

North America Drug Delivery Devices Market, By Route of Administration (Oral (Solid, Liquid, Semi-Solid), Injectable, Topical, Pulmonary (MDI, DPI, Nebulizers), Nasal, Ocular, Implantable, Transmucosal), By End-User (Hospitals, Ambulatory Surgery Centers/Clinics, Home Care Settings, Diagnostic Centers, Others), By Country (U.S., Canada, Mexico) –...